Structure-guided development of YEATS domain inhibitors by targeting π-π-π stacking. (December 2018)

• Record Type: Journal Article
• Authors: Li, Xin; Li, Xiao-Meng; Jiang, Yixiang; Liu, Zheng; Cui, Yiwen; Fung, Ka; Beelen, Stan; Tian, Gaofei; Wan, Liling; Shi, Xiaobing; Allis, C.; Li, Haitao; Li, Yuanyuan; Li, Xiang
• Is Part Of: Nature chemical biology. Volume 14:Number 12(2018)
• Page Start: 1140
• Page End: 1149
• Publication Date: 2018-12
• Subjects: Biochemistry -- Periodicals; Biochimie -- Périodiques; 572.05
• DOI: 10.1038/s41589-018-0144-y
• Languages: English
• ISSNs: 1552-4450

Abstract

Abstract Chemical probes of epigenetic 'readers' of histone post-translational modifications (PTMs) have become powerful tools for mechanistic and functional studies of their target proteins in normal physiology and disease pathogenesis. Here we report the development of the first class of chemical probes of YEATS domains, newly identified 'readers' of histone lysine acetylation (Kac) and crotonylation (Kcr). Guided by the structural analysis of a YEATS–Kcr complex, we developed a series of peptide-based inhibitors of YEATS domains by targeting a unique π-π-π stacking interaction at the proteins' Kcr recognition site. Further structure optimization resulted in the selective inhibitors preferentially binding to individual YEATS-containing proteins including AF9 and ENL with submicromolar affinities. We demonstrate that one of the ENL YEATS-selective inhibitors, XL-13m, engages with endogenous ENL, perturbs the recruitment of ENL onto chromatin, and synergizes the BET and DOT1L inhibition-induced downregulation of oncogenes in MLL-rearranged acute leukemia. An inhibitor of the YEATS domain was developed by targeting a unique π-π-π stacking in the YEATS–Kcr recognition. An ENL YEATS-selective inhibitor, XL-13m, helps probe the YEATS-dependent role of ENL in the leukemogenic transcription program.